Blocking Effect of AF-454 on Cough Hypersensitivity to Inhaled Irritants # a Pre-Clinical Study

Grants and Contracts Details

StatusActive
Effective start/end date9/29/2110/31/24

Funding

  • Merck and Company Inc: $627,821.00